Feng, Yu
Tang, Le
Wang, Hongyu
Liu, Yutao
Yang, Sheng
Lin, Lin
Hu, Xingsheng
Shi, Yuankai https://orcid.org/0000-0002-3342-4964
Funding for this research was provided by:
China National Major Project for New Drug Innovation (2017ZX09304015)
Beijing Xisike Clinical Oncology Research Foundation (Y-2019AZMS-0439)
Article History
Received: 13 September 2021
Accepted: 29 June 2022
First Online: 7 August 2022
Declarations
:
: The authors have declared that no competing interest exists.
: This was a retrospective study and approved by the Ethics Committee of Cancer Hospital, Chinese Academy of Medical Sciences.